Miyamoto, T.; Komuro, M.; Aihara, R.; Ohira, C.; Kaneki, M.; Iwashita, N.; Takagi, Y.; Miyasaka, A.; Kushiro, M.; Miyake, S.;
et al. Short-Term Oral Administration of 1.5 μg/kg bw/day of Deoxynivalenol Significantly Exacerbates Inflammatory and Itching Symptoms in a Mouse Model of Imiquimod-Induced Psoriasis. Toxins 2025, 17, 47.
https://doi.org/10.3390/toxins17020047
AMA Style
Miyamoto T, Komuro M, Aihara R, Ohira C, Kaneki M, Iwashita N, Takagi Y, Miyasaka A, Kushiro M, Miyake S,
et al. Short-Term Oral Administration of 1.5 μg/kg bw/day of Deoxynivalenol Significantly Exacerbates Inflammatory and Itching Symptoms in a Mouse Model of Imiquimod-Induced Psoriasis. Toxins. 2025; 17(2):47.
https://doi.org/10.3390/toxins17020047
Chicago/Turabian Style
Miyamoto, Takayoshi, Mariko Komuro, Ryota Aihara, Chiharu Ohira, Mao Kaneki, Naoki Iwashita, Yoshiichi Takagi, Atsushi Miyasaka, Masayo Kushiro, Shiro Miyake,
and et al. 2025. "Short-Term Oral Administration of 1.5 μg/kg bw/day of Deoxynivalenol Significantly Exacerbates Inflammatory and Itching Symptoms in a Mouse Model of Imiquimod-Induced Psoriasis" Toxins 17, no. 2: 47.
https://doi.org/10.3390/toxins17020047
APA Style
Miyamoto, T., Komuro, M., Aihara, R., Ohira, C., Kaneki, M., Iwashita, N., Takagi, Y., Miyasaka, A., Kushiro, M., Miyake, S., & Fukuyama, T.
(2025). Short-Term Oral Administration of 1.5 μg/kg bw/day of Deoxynivalenol Significantly Exacerbates Inflammatory and Itching Symptoms in a Mouse Model of Imiquimod-Induced Psoriasis. Toxins, 17(2), 47.
https://doi.org/10.3390/toxins17020047
